218 related articles for article (PubMed ID: 22157753)
21. Enhanced expression of adenovirus-mediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment.
Lim SJ; Paeng JC; Kim SJ; Kim SY; Lee H; Moon DH
J Nucl Med; 2007 Mar; 48(3):398-404. PubMed ID: 17332617
[TBL] [Abstract][Full Text] [Related]
22. KT5823 differentially modulates sodium iodide symporter expression, activity, and glycosylation between thyroid and breast cancer cells.
Beyer S; Lakshmanan A; Liu YY; Zhang X; Wapnir I; Smolenski A; Jhiang S
Endocrinology; 2011 Mar; 152(3):782-92. PubMed ID: 21209020
[TBL] [Abstract][Full Text] [Related]
23. The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.
Kogai T; Brent GA
Pharmacol Ther; 2012 Sep; 135(3):355-70. PubMed ID: 22750642
[TBL] [Abstract][Full Text] [Related]
24. Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid.
Alsayed Y; Uddin S; Mahmud N; Lekmine F; Kalvakolanu DV; Minucci S; Bokoch G; Platanias LC
J Biol Chem; 2001 Feb; 276(6):4012-9. PubMed ID: 11060298
[TBL] [Abstract][Full Text] [Related]
25. PI3K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancer.
Knostman KA; McCubrey JA; Morrison CD; Zhang Z; Capen CC; Jhiang SM
BMC Cancer; 2007 Jul; 7():137. PubMed ID: 17651485
[TBL] [Abstract][Full Text] [Related]
26. Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.
Willhauck MJ; Sharif-Samani B; Senekowitsch-Schmidtke R; Wunderlich N; Göke B; Morris JC; Spitzweg C
Breast Cancer Res Treat; 2008 May; 109(2):263-72. PubMed ID: 17636401
[TBL] [Abstract][Full Text] [Related]
27. MEK inhibition leads to lysosome-mediated Na+/I- symporter protein degradation in human breast cancer cells.
Zhang Z; Beyer S; Jhiang SM
Endocr Relat Cancer; 2013 Apr; 20(2):241-50. PubMed ID: 23404856
[TBL] [Abstract][Full Text] [Related]
28. Signaling through 3',5'-cyclic adenosine monophosphate and phosphoinositide-3 kinase induces sodium/iodide symporter expression in breast cancer.
Knostman KA; Cho JY; Ryu KY; Lin X; McCubrey JA; Hla T; Liu CH; Di Carlo E; Keri R; Zhang M; Hwang DY; Kisseberth WC; Capen CC; Jhiang SM
J Clin Endocrinol Metab; 2004 Oct; 89(10):5196-203. PubMed ID: 15472226
[TBL] [Abstract][Full Text] [Related]
29. Regulation of iodide uptake and sodium/iodide symporter expression in the mcf-7 human breast cancer cell line.
Arturi F; Ferretti E; Presta I; Mattei T; Scipioni A; Scarpelli D; Bruno R; Lacroix L; Tosi E; Gulino A; Russo D; Filetti S
J Clin Endocrinol Metab; 2005 Apr; 90(4):2321-6. PubMed ID: 15623812
[TBL] [Abstract][Full Text] [Related]
30. Manipulation of PBF/PTTG1IP phosphorylation status; a potential new therapeutic strategy for improving radioiodine uptake in thyroid and other tumors.
Smith VE; Sharma N; Watkins RJ; Read ML; Ryan GA; Kwan PP; Martin A; Watkinson JC; Boelaert K; Franklyn JA; McCabe CJ
J Clin Endocrinol Metab; 2013 Jul; 98(7):2876-86. PubMed ID: 23678037
[TBL] [Abstract][Full Text] [Related]
31. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells.
Spitzweg C; Joba W; Morris JC; Heufelder AE
Thyroid; 1999 Aug; 9(8):821-30. PubMed ID: 10482376
[TBL] [Abstract][Full Text] [Related]
32. Inverse Agonist of Estrogen-Related Receptor γ Enhances Sodium Iodide Symporter Function Through Mitogen-Activated Protein Kinase Signaling in Anaplastic Thyroid Cancer Cells.
Singh TD; Jeong SY; Lee SW; Ha JH; Lee IK; Kim SH; Kim J; Cho SJ; Ahn BC; Lee J; Jeon YH
J Nucl Med; 2015 Nov; 56(11):1690-6. PubMed ID: 26338896
[TBL] [Abstract][Full Text] [Related]
33. Switching from MAPK-dependent to MAPK-independent repression of the sodium-iodide symporter in 2D and 3D cultured normal thyroid cells.
Ingeson-Carlsson C; Nilsson M
Mol Cell Endocrinol; 2013 Dec; 381(1-2):241-54. PubMed ID: 23969277
[TBL] [Abstract][Full Text] [Related]
34. Reduction of stimulated sodium iodide symporter expression by estrogen receptor ligands in breast cancer cells.
Cheong SJ; Jang D; Jeong HJ; Lim ST; Sohn MH; Katzenellenbogen JA; Kim DW
Nucl Med Biol; 2011 Feb; 38(2):287-94. PubMed ID: 21315285
[TBL] [Abstract][Full Text] [Related]
35. microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.
Lakshmanan A; Wojcicka A; Kotlarek M; Zhang X; Jazdzewski K; Jhiang SM
Endocr Relat Cancer; 2015 Feb; 22(1):11-21. PubMed ID: 25404690
[TBL] [Abstract][Full Text] [Related]
36. CCAAT/enhancer-binding protein-homologous protein expression and transcriptional activity are regulated by 3',5'-cyclic adenosine monophosphate in thyroid cells.
Pomerance M; Carapau D; Chantoux F; Mockey M; Correze C; Francon J; Blondeau JP
Mol Endocrinol; 2003 Nov; 17(11):2283-94. PubMed ID: 12907753
[TBL] [Abstract][Full Text] [Related]
37. Sterol regulatory element-binding proteins are regulators of the sodium/iodide symporter in mammary epithelial cells.
Wen G; Pachner LI; Gessner DK; Eder K; Ringseis R
J Dairy Sci; 2016 Nov; 99(11):9211-9226. PubMed ID: 27614840
[TBL] [Abstract][Full Text] [Related]
38. Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer.
Yao C; Pan Y; Li Y; Xu X; Lin Y; Wang W; Wang S
Oncol Rep; 2015 Jul; 34(1):59-66. PubMed ID: 25955347
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway.
Mao L; Yuan L; Slakey LM; Jones FE; Burow ME; Hill SM
Breast Cancer Res; 2010; 12(6):R107. PubMed ID: 21167057
[TBL] [Abstract][Full Text] [Related]
40. TGF-β1-induced cell migration in pancreatic carcinoma cells is RAC1 and NOX4-dependent and requires RAC1 and NOX4-dependent activation of p38 MAPK.
Witte D; Bartscht T; Kaufmann R; Pries R; Settmacher U; Lehnert H; Ungefroren H
Oncol Rep; 2017 Dec; 38(6):3693-3701. PubMed ID: 29039574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]